Inside Therapeutics

keyboard_backspaceBack to Home

Contact

location_on

25-27 rue de la grand font
16000 Angouleme
France

public

https://insidetx.com/

Robin Oliveres
Chief Business Officier
mail

robin.oliveres@insidetx.com

call

+33676376279

About us

At InsideTX, we are revolutionizing nanoparticle manufacturing, to unlock the full potential of RNA-LNP medicines.

At the convergence of microfluidics and biotechnology, we strive to provide laboratories, biotech, and pharma companies with the ultimate nanoparticle synthesis capabilities by solving three of the biggest challenges of the RNA-LNP revolution:
- Easing screeening
- ensuring seamless scalability all along the development process
- allowing for continuous production.

Leveraging our patented technology, our complementary team is developping the only streamlined nanoparticle synthesis platform that accelerates your screening to production time while improving your development chances of success.

Business offer

At Inside Therapeutics, we offer nanoparticle synthesis systems.

Our first turnkey system, TAMARA, allows simplified access to the most advanced nanoparticle synthesis technologies. TAMARA has the following features:

- Microfluidic-based: For optimal control of nanoparticle characteristics (size, PDI, encapsulation percentage...).
- Simple and easy to use: Complete a full synthesis and cleaning cycle in less than 2 minutes.
- Volumes: Covers the range from 0.2 to 5 mL, making it perfect for screening and preclinical development stages.
- Cleanable: Clean the chips and reservoirs to reuse them multiple times (unlike other platforms).

For more information, contact us or visit: https://insidetx.com/product/tamara/

Activities

    Categories

    • Technology Supplier

    Therapeutic applications

    • Oncology
    • Infectiology
    • Immunology

    Expertises

    Prophylactic Vaccines Directory
    • Vaccine: antigen format platforms
    • DNA plasmid vaccine
    • mRNA vaccine
    • Lipid delivery vehicle
    • Vaccine delivery/Administration routes
    • Delivery/ Encapsulation
    • Polymeric Nanoparticles
    • Lipid Nanoparticles
    • Nano emulsions
    • Bioproduction GMP
    • Vaccine platform type
    • mRNA vaccine
    • Lipid delivery vehicle
    • Manufacturing Volume
    • Small volume (< 100 L) adjusted to phase I/II needs: specify volume
Français English